CD4 and neoplasm: Taken together, our results show that combined OK-432- and PSK-activation of DC/tumor contributes to enhance their ability through a fusion process to stimulate IFN-γ-producing CD4+ and CD8+ T cells and may enable stronger CTL responses to be generated.